Financials Jiangxi Rimag Group Co., Ltd.
Equities
2522
CNE100006HX9
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.96 HKD | -2.81% | -0.22% | -.--% |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 592 | 784.4 | 928.9 |
EBITDA 1 | -180.2 | 175.6 | 217.9 |
EBIT 1 | -307.3 | 32.87 | 62.98 |
Operating Margin | -51.9% | 4.19% | 6.78% |
Earnings before Tax (EBT) 1 | -362.7 | 0.935 | 43.38 |
Net income 1 | -360.7 | 0.364 | 44.42 |
Net margin | -60.93% | 0.05% | 4.78% |
EPS 2 | -1.172 | 0.001000 | 0.1310 |
Free Cash Flow | - | -129.6 | 59.66 |
FCF margin | - | -16.52% | 6.42% |
FCF Conversion (EBITDA) | - | - | 27.39% |
FCF Conversion (Net income) | - | - | 134.32% |
Dividend per Share | - | - | - |
Announcement Date | 24-05-29 | 24-05-29 | 24-05-29 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 65.1 | 133 | 171 |
Net Cash position 1 | - | - | - |
Leverage (Debt/EBITDA) | -0.3613 x | 0.7597 x | 0.7846 x |
Free Cash Flow | - | -130 | 59.7 |
ROE (net income / shareholders' equity) | - | -1.15% | 2.76% |
ROA (Net income/ Total Assets) | - | 1.02% | 2.04% |
Assets 1 | - | 35.83 | 2,182 |
Book Value Per Share 2 | 4.120 | 3.760 | 3.820 |
Cash Flow per Share 2 | 1.590 | 1.010 | 0.5600 |
Capex 1 | 138 | 267 | 92.3 |
Capex / Sales | 23.31% | 34.06% | 9.94% |
Announcement Date | 24-05-29 | 24-05-29 | 24-05-29 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 820M | |
-20.01% | 8.43B | |
+69.46% | 4.35B | |
+9.51% | 2.78B | |
-2.10% | 2.64B | |
-56.54% | 1.74B | |
-16.69% | 1.48B | |
+17.87% | 1.22B | |
-49.60% | 1.02B | |
-21.78% | 948M |
- Stock Market
- Equities
- 2522 Stock
- Financials Jiangxi Rimag Group Co., Ltd.